Clinical Study
The rs2071559 AA VEGFR-2 Genotype Frequency Is Significantly Lower in Neovascular Age-Related Macular Degeneration Patients
Table 3
Differences of VEGFR-2 alleles and genotypes between controls and patients.
| VEGFR-2 SNPs | Controls | AMD | Total |
| rs2071559* | | | | A | 89 (57.05%) | 107 (44.58%) | 196 | G | 67 (42.95%) | 133 (55.42%) | 200 |
| Total | 156 (100%) | 240 (100%) | 396 |
| rs1870377 | | | | A | 31 (19.87%) | 63 (26.25%) | 94 | T | 125 (80.13%) | 177 (73.75%) | 302 |
| Total | 156 (100%) | 240 (100%) | 396 |
| rs2071559° | | | | AA | 27 (34.62%) | 22 (18.33%) | 49 | AG/GG | 51 (65.38%) | 98 (81.67%) | 149 |
| Total | 78 (100%) | 120 (100%) | 198 |
| rs2071559 | | | | GG | 16 (20.51%) | 35 (29.17%) | 51 | AG/AA | 62 (79.49%) | 85 (70.83%) | 147 |
| Total | 78 (100%) | 120 (100%) | 198 |
| rs1870377 | | | | AA | 3 (3.85%) | 10 (8.33%) | 13 | AT/TT | 75 (96.15%) | 110 (91.67%) | 185 |
| Total | 78 (100%) | 120 (100%) | 198 |
| rs1870377 | | | | TT | 50 (64.10%) | 67 (55.84%) | 117 | AT/AA | 28 (35.90%) | 53 (44.16%) | 81 |
| Total | 78 (100%) | 120 (100%) | 198 |
|
|
*P = 0.0153, , .
°P = 0.0095, , .
|